[go: up one dir, main page]

MA27046A1 - Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens. - Google Patents

Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.

Info

Publication number
MA27046A1
MA27046A1 MA27460A MA27460A MA27046A1 MA 27046 A1 MA27046 A1 MA 27046A1 MA 27460 A MA27460 A MA 27460A MA 27460 A MA27460 A MA 27460A MA 27046 A1 MA27046 A1 MA 27046A1
Authority
MA
Morocco
Prior art keywords
oxazolidinon
derivatives
new
antibacterial agents
antibacterial
Prior art date
Application number
MA27460A
Other languages
English (en)
Inventor
Mancini Marisabel Mourelle
Clotet Juan Huguet
Rodriguez Jose Hidalgo
Castillo Juan Carlos Del
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of MA27046A1 publication Critical patent/MA27046A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA27460A 2001-06-27 2003-12-23 Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens. MA27046A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101559A ES2186550B2 (es) 2001-06-27 2001-06-27 Nuevos derivados de oxazolidinonas como antibacterianos.

Publications (1)

Publication Number Publication Date
MA27046A1 true MA27046A1 (fr) 2004-12-20

Family

ID=8498288

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27460A MA27046A1 (fr) 2001-06-27 2003-12-23 Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.

Country Status (29)

Country Link
US (1) US20040147545A1 (fr)
EP (1) EP1401834A1 (fr)
JP (1) JP2004521147A (fr)
KR (1) KR20040030712A (fr)
CN (1) CN1520412A (fr)
AP (1) AP2003002942A0 (fr)
AR (1) AR035254A1 (fr)
BG (1) BG108498A (fr)
BR (1) BR0210667A (fr)
CA (1) CA2450982A1 (fr)
CO (1) CO5540387A2 (fr)
CR (1) CR7195A (fr)
CZ (1) CZ2004101A3 (fr)
EA (1) EA200400086A1 (fr)
EE (1) EE200400004A (fr)
ES (1) ES2186550B2 (fr)
HR (1) HRP20031063A2 (fr)
HU (1) HUP0400370A2 (fr)
IL (1) IL159434A0 (fr)
IS (1) IS7088A (fr)
MA (1) MA27046A1 (fr)
MX (1) MXPA04000185A (fr)
NO (1) NO20035791L (fr)
NZ (1) NZ530206A (fr)
OA (1) OA12639A (fr)
PE (1) PE20030134A1 (fr)
PL (1) PL365476A1 (fr)
SK (1) SK572004A3 (fr)
WO (1) WO2003002560A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (fr) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibiotiques a action duale renfermant une oxazolidinone et une quinolone ou une fraction de naphthyridinone
EP1620098B1 (fr) * 2003-04-30 2008-06-11 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Utilisation d'antibiotiques hybrides d'oxazolidinone-quinoleine destines au traitement de l'anthrax et d'autres infections
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
WO2005051933A1 (fr) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Procede ameliore de synthese d'ester test-butylique d'acide 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylique, compose intermediaire cle de la preparation d'agents antimicrobiens a l'oxazolidinone, et composes ainsi prepares
EP1557416A1 (fr) * 2004-01-23 2005-07-27 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Oxazolidinone-quinolone antibiotiques hybrides
CN106957316A (zh) * 2003-12-18 2017-07-18 莫弗凯姆联合化学股份公司 噁唑烷酮‑喹诺酮杂化物抗生素
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
WO2009044777A1 (fr) 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory Dérivé d'oxazolidinone avec hétérocycle à 7 chaînons
PT2296651E (pt) * 2008-05-09 2012-10-01 Actelion Pharmaceuticals Ltd Derivados de 5-hidroximetil-oxazolidina-2-ona para o tratamento de doenças intestinais bacterianas
CN105246476B (zh) 2013-05-28 2019-11-15 莫弗凯姆联合化学股份公司 含噁唑烷酮-喹诺酮的联合疗法在治疗细菌感染中的应用
EP3003289B1 (fr) 2013-05-28 2019-02-20 Morphochem Aktiengesellschaft für kombinatorische Chemie L'administration d'antibactériens hybrides de oxazolidinone-quinolone
CN107286111B (zh) * 2016-03-30 2020-06-19 广东赛法洛药业有限公司 一种噁唑烷酮化合物的制备方法
CN107286182A (zh) * 2016-04-12 2017-10-24 李靖 新型噁唑烷酮‑氟喹诺酮衍生物及用途
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
GB201708606D0 (en) 2017-05-30 2017-07-12 King S College London Antibiotic resistance breakers
ES2952989T3 (es) * 2017-11-29 2023-11-07 Bugworks Res Inc Compuestos heterocíclicos antibacterianos y su síntesis
CN111087409B (zh) * 2018-10-24 2021-06-08 江阴安博生物医药有限公司 一种喹诺酮类化合物及其制备方法和应用
CN117567455A (zh) * 2019-12-11 2024-02-20 华创合成制药股份有限公司 一种新型噁唑烷酮类化合物及其合成方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE444566B (sv) * 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
US5153203A (en) * 1989-03-30 1992-10-06 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and salts thereof, preparation processes thereof, and antibacterial agents containing the same
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
DK0788498T3 (da) * 1994-10-26 2001-11-05 Upjohn Co Phenyloxazolidinoner med antimikrobiel virkning
CA2245179A1 (fr) * 1996-01-31 1997-08-07 Sankyo Company, Limited Medicaments pour prevenir ou soigner le sida
CN1319952C (zh) * 1996-04-11 2007-06-06 法玛西雅厄普约翰美国公司 制备唑烷酮胺的方法
GB9614236D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
EP1401834A1 (fr) 2004-03-31
CO5540387A2 (es) 2005-07-29
CR7195A (es) 2004-03-05
PL365476A1 (en) 2005-01-10
WO2003002560A1 (fr) 2003-01-09
IL159434A0 (en) 2004-06-01
NZ530206A (en) 2005-07-29
IS7088A (is) 2003-12-22
ES2186550B2 (es) 2003-11-16
HRP20031063A2 (en) 2004-04-30
ES2186550A1 (es) 2003-05-01
JP2004521147A (ja) 2004-07-15
CZ2004101A3 (cs) 2004-07-14
EE200400004A (et) 2004-02-16
SK572004A3 (en) 2004-08-03
KR20040030712A (ko) 2004-04-09
CA2450982A1 (fr) 2003-01-09
OA12639A (en) 2006-06-15
EA200400086A1 (ru) 2004-06-24
US20040147545A1 (en) 2004-07-29
AR035254A1 (es) 2004-05-05
AP2003002942A0 (en) 2003-12-24
BG108498A (en) 2005-03-31
CN1520412A (zh) 2004-08-11
MXPA04000185A (es) 2004-03-18
NO20035791L (no) 2004-02-19
PE20030134A1 (es) 2003-04-04
BR0210667A (pt) 2004-10-05
HUP0400370A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
MA27046A1 (fr) Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.
FR20C1039I2 (fr) Derives de l'uk-2a
MA26972A1 (fr) Derives du tetralone en tant qu'agents anti-tumeur
FR15C0086I2 (fr) Derives d'hydroxamate en tant qu'inhibiteurs de desacetylase
FR18C1024I2 (fr) Derives d'heterocyclocarboxamide
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
MA26932A1 (fr) Derives d'imidazole.
BR0202290B1 (pt) ôaparato de moldagemö.
MA27012A1 (fr) Derives de dihydro-benzo [b] [1,4] diazepin-2-one en tant qu'antagonistes ii de mglur2
NO20043022L (no) 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister
BR0104326B1 (pt) ôcomposição aquosa de revestimentoö.
DE60202270D1 (de) 4,5-dihydro-1h-pyrazolderivate mit cb1-antagonistischer wirkung
MA26782A1 (fr) Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2.
DE60131971D1 (de) 1,3,8-TRIAZA-SPIROi4,5 DECAN-4-ONDERIVATIVE ALS NEUROKININREZEPTORANTAGONISTEN
BR0216099B1 (pt) "conjunto de desgaste".
MA27083A1 (fr) Derives de nicotine ou d'isonicotine benzothiazole
MA26958A1 (fr) Derives de 2-phenylaminoimidazoline phenyl cetone substituee en tant qu'antagonistes ip
MA26848A1 (fr) Derives d'heterocyclo-alkylsufonylpyrazole nouveaux servant d'agents anti-inflammatoires/analgesiques.
EP1426370A4 (fr) Derive de propanolamine a noyau 1,4-benzodioxane
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
DE60138903D1 (de) N-(1,2,4-triazoloazinyl)thiophensulfonamid-verbindungen als herbizide
MA27094A1 (fr) Derives triazolo-quinoline utiles en tant que ligands recepteurs d'adenosine.
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
MA26941A1 (fr) Nouveaux derives d'aminocyclohexane